Daily Financial Update
Good morning, it’s Tuesday, February 3, 2026 — and yes, if you slept in, you’re already behind.
Market Pulse: Tech names ripped as Palantir’s unexpected Q4 surge ignited optimism around AI spend by U.S. enterprises, sending a charge through growth sectors.
Key Movers: Headlines like “PLTR stock price today: Palantir Q4 earnings beat estimates as AI demand fuels record U.S. growth and bullish 2026 outlook” and “Bitcoin: Leverage unwinds as BTC slips 10% monthly -Stabilization ahead?” dominated chatter.
Macro & Politics: India’s $10 billion rare‐earth push to break China’s grip signals a tectonic shift in global tech and defense supply chains.
What’s Next: Eyes on Disney and Tyson earnings after the open—expect fireworks or whiplash.
Market Commentary
What everyone’s missing is how the AI euphoria around Palantir and Tesla’s robot gambit is masking a brewing geopolitical showdown. While the street cheers record U.S. sales growth, the India rare‐earth splurge and Kurdistan gas maneuvers are quietly rewriting supply‐chain rules. That’s the real setup if you’re looking past the hype.
Consider the link between India’s moves to dethrone China in rare earths and Tesla’s pivot toward AI robots over EVs (“As Tesla Doubles Down on AI and Robots, EVs Look More Like a Side Hustle”). One’s a state‐led strategic bet, the other’s a corporate play for the next frontier—together they underscore how resource politics and tech ambition feed each other.
Action‐oriented takeaway: position for volatility. If you’re not scouting rare‐earth miners or pipeline stocks tied to the TurkStream headlines, you’re leaving alpha on the table. Keep a close watch on Middle East export routes and miners stepping into China’s old role.
📈 Breaking Financial News
PLTR stock price today: Palantir Q4 earnings beat estimates as AI demand fuels record U.S. growth and bullish 2026 outlook
Palantir Technologies has exceeded Wall Street's fourth-quarter expectations. Strong demand for its artificial intelligence tools from businesses and the US government fueled this success. The company reported significant revenue growth, particularly in its U…
Palantir Q4 earnings beat Wall Street estimates on strong sales to US businesses
Palantir reported earnings after the bell Monday.
Earnings live: Disney, Tyson earnings beat expectations, with Palantir results on deck
More Big Tech earnings are ahead from Amazon and Alphabet.
Bitcoin: Leverage unwinds as BTC slips 10% monthly -Stabilization ahead?
Bitcoin’s correction deepens as leverage unwinds and Open Interest drops sharply.
India Pours Over $10 Billion Into Rare Earths to Cut China Dependence
India’s Finance Ministry has unveiled a budget proposal for the current financial year that will boost domestic rare earths mining and the clean energy sector as part of a broader effort to break global supply chain monopolies–particularly China’s dominance-…
Alert: The DeFi Token Set to Explode as Markets Recover
This isn't speculation – this platform's role is so essential to crypto's financial system that its current price defies all logic. Just Released: The DeFi token set for massive gains as markets heat up – only $3!
🔍 Market Analysis & Insights
Kurdistan’s New Gas Play Just Exposed the Real Battle for Iraq
The semi-autonomous Kurdistan Region of Iraq, centred in Erbil, has a significance way beyond its size, oil and gas output, and military capabilities. It is at the heart of the superpower battle for Iraq, which itself is seen by Washington, London, Beijing an…
Central Asia Looks West as It Rewires Its Energy System
Central Asia is emerging from the shadow of Russia and Moscow’s grip on its economy and energy supply. In recent years, several regional and European projects, as well as China’s inroads into the Central Asian economies, have the potential to make Kazakhstan,…
Dermal Fillers Market to Surge from USD 8.51 Billion in 2025 to USD 34.64 Billion by 2035 at 15.07% CAGR
The global dermal fillers market size was valued at USD 8.51 billion in 2025 and is predicted to hit around USD 34.64 billion by 2035, rising at a 15.07% CAGR, a study published by Towards Healthcare a sister firm of Precedence Research. The global dermal fil…
FDA In Brief: FDA affirms its commitment to efficient adoption of Risk Evaluation and Mitigation Strategy plans and to making sure they do not impede generic drug development
FDA issues guidance for Risk Evaluation and Mitigation Strategy plans and to ensuring REMS do not impede generic drug development
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
60 Degrees Pharmaceuticals partners with GoodRx to cut ARAKODA® costs up to 30%, expanding affordable malaria prevention at 70,000+ pharmacies….
Wall Street's Secret Crypto Accumulation Exposed
This protocol is fueling billions in transactions while most investors chase headlines… creating what could be the most asymmetric opportunity of 2025! Revealed: Get the name of Wall Street's favorite crypto for just $3 before it potentially skyrockets!
💰 Investment Opportunities
The AI Bubble Debate: Can Both Bulls and Bears Be Right?
AI-exposed companies are heavily investing in CapEx to build the infrastructure capable of sustaining current and future AI demand Bears see similarities with the dot-com bubble: too many startups, stretched valuations, and execution risk Bulls argue that AI …
Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™
WARREN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery…
As Tesla Doubles Down on AI and Robots, EVs Look More Like a Side Hustle
Earlier this month, Tesla lost its title as the best-selling electric vehivle maker in the world to Chinese company BYD.
Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
Pharming Group received an FDA Complete Response Letter for its sNDA for Joenja® (leniolisib) in children aged 4–11 with APDS…
Singapore Women's Health Devices Market AI & Automation Outlook
Download Sample Get Special Discount Singapore Women's Health Devices Market Size, Strategic Opportunities & Forecast (2026-2033) Market size (2024): USD 15.2 billion · Forecast (2033): USD 25.
The Comeback of the Century: Wall Street Wrote Him Off…
But Elon's $3 Trillion Comeback Could Begin Soon Elon Musk was declared washed up and finished. But any day now, he could unveil a new technology that outshines Tesla, SpaceX, even PayPal… a breakthrough big enough to solve America's toughest problem, make President Trump a hero to the Western World… and spark a $3 trillion boom. Early investors could see massive gains. Details here.
